ICD-10 Coding for Medication Review(T37.0, T37.2, Z79.01)
Learn how to accurately code and document medication reviews using ICD-10 codes, including Z79.899 for long-term drug therapy.
Complete code families applicable to Medication Review
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z79.899 | Other long-term (current) drug therapy | Use for documenting long-term use of medications not covered by specific Z79 codes. |
|
| T37.2x5A | Adverse effect of antimalarials and drugs acting on other blood protozoa | Use when adverse effects from antimalarials are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMedication Review
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Medication Review.
Omitting adverse effect documentation
Impact
Clinical: Potential for missed adverse reactions, Regulatory: Non-compliance with documentation standards, Financial: Risk of claim denials
Mitigation
Always document adverse effects with T codes, Link adverse effects to the specific medication
Using Z79.899 without the primary condition code
Impact
Reimbursement: May result in denied claims or reduced reimbursement., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate representation of patient health data.
Mitigation
Always document the primary condition code first.
Medication Documentation
Impact
Incomplete documentation of long-term medication use.
Mitigation
Implement regular audits of medication lists and documentation.